About this trial
The study will test the efficacy of drug eluting balloon(DEB) for non-atherosclerotic renal artery stenosis. The DEB (paclitaxel eluting balloon) will be used in the intervention group, while the plain old balloon(POB) will be used in the control group. The primary outcome is the effect of blood pressure control.
Eligibility criteria
Qualifiers
age between 18y and 45y.
with ≥ 60% stenosis in at least one renal artery.
with hypertension (systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥ 90 mmHg).
patients with no severe renal insufficiency (eGFR>30 ml/min, length of the kidney ≥ 7cm).
Disqualifiers
With apparent atherosclerotic risk factors.
With renal intervention or surgery history.
With congenital anatomical anomaly.
With severe renal insufficiency (length of the target kidney < 7cm, total
Trial design
Treatments tested in this trial
- Parallel Assignment